ZA200800926B - Oral suspension of prednisolone acetate - Google Patents

Oral suspension of prednisolone acetate

Info

Publication number
ZA200800926B
ZA200800926B ZA2008/00926A ZA200800926A ZA200800926B ZA 200800926 B ZA200800926 B ZA 200800926B ZA 2008/00926 A ZA2008/00926 A ZA 2008/00926A ZA 200800926 A ZA200800926 A ZA 200800926A ZA 200800926 B ZA200800926 B ZA 200800926B
Authority
ZA
South Africa
Prior art keywords
oral suspension
prednisolone acetate
prednisolone
acetate
oral
Prior art date
Application number
ZA2008/00926A
Other languages
English (en)
Inventor
Satish Asotra
Avraham Yacobi
Shen Gao
Original Assignee
Taro Pharmaceutical North America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taro Pharmaceutical North America Inc filed Critical Taro Pharmaceutical North America Inc
Publication of ZA200800926B publication Critical patent/ZA200800926B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
ZA2008/00926A 2005-08-04 2008-01-29 Oral suspension of prednisolone acetate ZA200800926B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70537005P 2005-08-04 2005-08-04
PCT/US2006/030140 WO2007019184A2 (en) 2005-08-04 2006-08-03 Oral suspension of prednisolone acetate

Publications (1)

Publication Number Publication Date
ZA200800926B true ZA200800926B (en) 2012-04-24

Family

ID=37727875

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2008/00926A ZA200800926B (en) 2005-08-04 2008-01-29 Oral suspension of prednisolone acetate

Country Status (11)

Country Link
US (4) US7799331B2 (enExample)
EP (2) EP1909798A4 (enExample)
JP (2) JP2009503097A (enExample)
KR (1) KR20080044245A (enExample)
CN (1) CN101247786A (enExample)
AU (1) AU2006278620B2 (enExample)
CA (1) CA2616112A1 (enExample)
IL (1) IL189257A0 (enExample)
NZ (1) NZ566117A (enExample)
WO (1) WO2007019184A2 (enExample)
ZA (1) ZA200800926B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799331B2 (en) * 2005-08-04 2010-09-21 Taro Pharmaceutical North America, Inc. Oral suspension of prednisolone acetate
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
JP5226661B2 (ja) * 2006-04-06 2013-07-03 ターロ ファーマシューティカルズ ノース アメリカ インコーポレイテッド 親水コロイド重合体を含む新規な耐流出性製剤
CN101888829A (zh) * 2007-10-09 2010-11-17 诺瓦提斯公司 缬沙坦的药物制剂
DK3354276T3 (da) * 2007-11-13 2020-03-30 Meritage Pharma Inc Sammensætninger til behandlingen af gastrointestinal inflammation
US20090143343A1 (en) * 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
EP2328553B1 (en) * 2008-08-20 2020-06-10 The Regents of The University of California Corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
EP2440210A4 (en) * 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
AU2017260327B2 (en) * 2016-05-06 2018-12-20 Harrow Ip, Llc Pharmaceutical Ophthalmic compositions and methods for fabricating thereof
US9956158B2 (en) * 2016-09-08 2018-05-01 Synergistic Therapeutics, Llc Topical hair growth formulation

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265823A (en) * 1979-01-04 1981-05-05 Robert E. Kosinski Aurothiosteroids
US4448774A (en) 1982-12-22 1984-05-15 Fisons Corporation Steroid formulation
US5145675A (en) * 1986-03-31 1992-09-08 Advanced Polymer Systems, Inc. Two step method for preparation of controlled release formulations
EP0653209A4 (en) * 1992-07-30 1997-03-19 Tokyo Tanabe Co Remedy for inflammatory intestinal diseases.
IL108366A (en) 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
US5881926A (en) 1993-03-11 1999-03-16 Taro Pharmaceutical Industries, Ltd. Pharmaceutical compositions in semisolid form and a device for administration thereof
US20030203976A1 (en) * 1993-07-19 2003-10-30 William L. Hunter Anti-angiogenic compositions and methods of use
US5480914A (en) 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
US5763449A (en) * 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
US6071523A (en) 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
WO2000012137A1 (en) 1998-09-02 2000-03-09 Allergan Sales, Inc. Preserved cyclodextrin-containing compositions
US20040022862A1 (en) * 2000-12-22 2004-02-05 Kipp James E. Method for preparing small particles
WO2002058662A2 (en) * 2001-01-24 2002-08-01 Oraceutical Llc Topical oral care compositions
BR0213100A (pt) 2001-10-05 2004-11-30 Combinatorx Inc Combinações para o tratamento de distúrbios imuniinflamatórios
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
WO2003049745A1 (en) 2001-12-12 2003-06-19 Pharmacia Corporation Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
ATE541562T1 (de) 2002-06-17 2012-02-15 Taro Pharmaceuticals Usa Inc Ibuprofen-suspension
WO2004112800A1 (en) * 2003-06-19 2004-12-29 Bodor Nicholas S Enhancement of activity and/or duration of action of selected anti-inflammatory steroids
US20050153946A1 (en) 2003-12-24 2005-07-14 Collegium Pharmaceuticals, Inc. Temperature-stable formulations, and methods of development thereof
JP2007533697A (ja) * 2004-04-22 2007-11-22 デュオコート エービー グルココルチコイド救急治療用の医薬組成物
US6969706B1 (en) * 2004-05-12 2005-11-29 Allergan, Inc. Preserved pharmaceutical compositions comprising cyclodextrins
US7799331B2 (en) 2005-08-04 2010-09-21 Taro Pharmaceutical North America, Inc. Oral suspension of prednisolone acetate

Also Published As

Publication number Publication date
CA2616112A1 (en) 2007-02-15
US8461139B2 (en) 2013-06-11
US20070031459A1 (en) 2007-02-08
JP2009503097A (ja) 2009-01-29
US20130143853A1 (en) 2013-06-06
EP2630951A1 (en) 2013-08-28
JP2013014634A (ja) 2013-01-24
WO2007019184A2 (en) 2007-02-15
KR20080044245A (ko) 2008-05-20
EP1909798A2 (en) 2008-04-16
WO2007019184A3 (en) 2007-09-20
US20100324007A1 (en) 2010-12-23
EP1909798A4 (en) 2010-10-27
AU2006278620A1 (en) 2007-02-15
AU2006278620B2 (en) 2012-02-02
IL189257A0 (en) 2008-08-07
NZ566117A (en) 2011-06-30
US8206727B2 (en) 2012-06-26
CN101247786A (zh) 2008-08-20
US7799331B2 (en) 2010-09-21
US20120238534A1 (en) 2012-09-20

Similar Documents

Publication Publication Date Title
IL189257A0 (en) Oral suspension of prednisolone acetate
ZA200504239B (en) Pharmaceutical suspension composition
ZA200801742B (en) Bazedoxifene acetate formulations and manufacturing process thereof
SI1802579T1 (sl) Derivati 3-arilaminopiridina
IL185757A0 (en) Methods of decreasing calcifcation
ZA200803555B (en) Manufacture of esters
EP1970024A4 (en) SYSTEM OF FULLY ADJUSTABLE LATCHES
EP1885394A4 (en) PRODUCTION OF MULTIVALENT PARTICLES LIKE VIRUSES
IL213474A0 (en) Processes for the preparation of cyclopropyl-amide derivatives
PT2380573E (pt) Acetato de eslicarbazepina e métodos de utilização
EP1912499A4 (en) PREPARATION OF MONTELUKAST
EP1845979A4 (en) METHOD AND COMPOSITIONS FOR REDUCING STORAGE PRODUCTION
GB0509720D0 (en) Configuration of VPNs
ZA200609333B (en) Process for the production of ethyl acetate
ZA200710664B (en) Processes for the preparation of docetaxel
IL187855A0 (en) Processes for the preparation of docetaxel
IL189698A0 (en) Thiomorpholine derivatives and processes for the preparation thereof
GB0506832D0 (en) Oral insert
PL1902020T3 (pl) Pochodne selenoaminokwasów
GB0712351D0 (en) Synthesis of 5-n-alkyresorcinols from 3,5-dibenzyloxybenzaldehyde and from 8-(3,5 dibenzyloxyphenl) octanal
PL116075U1 (en) Air outlet of door-air curtain
GB0502580D0 (en) Manufacture of dentures
PL1749531T3 (pl) Zastosowanie doustnej zawiesiny zawierającej octan megestrolu do leczenia astmy oskrzelowej
PL375175A1 (en) Set for aerodynamic cleaning of combine-harvester
ZA200709864B (en) Eslicarbazepine acetate and methods of use